Today: 9 April 2026
Wealthfront IPO Prices at $14, Raises $485 Million as WLTH Debuts on Nasdaq and Rings the Opening Bell
12 December 2025
5 mins read

Wealthfront IPO Prices at $14, Raises $485 Million as WLTH Debuts on Nasdaq and Rings the Opening Bell

NEW YORK — Dec. 12, 2025 — Wealthfront, the digital wealth management platform best known for automated investing and high-yield cash products, has officially entered the public markets. The company priced its initial public offering at $14.00 per share, selling 34,615,384 shares—a deal size of about $485 million—and began its first day of trading on the Nasdaq Global Select Market under the ticker WLTH. GlobeNewswire+2Reuters+2

The debut is being closely watched across fintech and wealth management because Wealthfront is positioning itself as a rare, relatively pure-play “robo-advisor” brand stepping into public-market scrutiny at a moment when investors have been selective about consumer fintech listings. Axios called the IPO “the latest test” of appetite for consumer fintechs after several high-profile debuts have lost momentum after their initial pops. Axios

Wealthfront IPO price, size, and valuation: what’s confirmed

Wealthfront’s IPO was priced at the top of its marketed range (previously $12 to $14). Reuters reported that the offering valued Wealthfront at about $2 billion (based on shares outstanding), while other deal trackers and analysts have emphasized a higher fully diluted valuation that includes options and other potential shares. Reuters+1

Here’s how those numbers fit together based on today’s reporting:

  • IPO price: $14.00 per share GlobeNewswire
  • Shares sold in the IPO: 34,615,384 GlobeNewswire
  • Gross proceeds: ~ $485 million (34.6M × $14) GlobeNewswire+1
  • Market value (non–fully diluted): around $2.0–$2.05 billion (varies by calculation method used in reports) Reuters+2IPO Scoop+2
  • Fully diluted valuation: about $2.6 billion (including options/potential shares), per Axios and Renaissance Capital Axios+1

That split matters because readers may see different “valuation” headlines that are both accurate—just based on different share counts.

Nasdaq opening bell: Wealthfront’s first-day spotlight in Times Square

To mark its “public listing day,” Wealthfront also appeared at the Nasdaq MarketSite in Times Square for a bell ceremony scheduled for 9:15 AM–9:45 AM ET. Nasdaq said CEO David Fortunato, co-founder and chairman Andy Rachleff, and co-founder Dan Carroll rang the Opening Bell. Nasdaq+1

While bell ceremonies are largely symbolic, they’re also part of how newly public companies signal confidence and build brand visibility with retail investors—particularly for a consumer-facing finance product that has historically marketed itself to “digital natives.” Nasdaq+1

Who sold shares, who gets the money, and who ran the deal

One of the biggest practical questions in any IPO is: Is this fresh capital for the company—or mostly insiders cashing out?

In Wealthfront’s case, the offering was a mix:

  • 21,468,038 shares were sold by Wealthfront (primary shares) GlobeNewswire
  • 13,147,346 shares were sold by existing shareholders (secondary shares) GlobeNewswire
  • Wealthfront said it will not receive proceeds from the shares sold by those selling shareholders GlobeNewswire

The underwriting roster is a heavyweight lineup. Wealthfront’s press release lists Goldman Sachs and J.P. Morgan as lead book-running managers, with Citigroup, Wells Fargo Securities, and RBC Capital Markets as active book-runners, plus additional co-managers. GlobeNewswire

There is also a standard “greenshoe” option: Wealthfront granted underwriters a 30-day option to buy up to 5,192,308 additional shares. GlobeNewswire

The IPO is expected to close on Dec. 15, 2025, subject to customary conditions. GlobeNewswire

Early trading: WLTH indicated to open higher

As trading began Friday, multiple reports indicated that WLTH was poised to open above its IPO price. Barron’s reported an indicated open around $15.50 (about an 11% premium), and Investing.com published a similar indication. Barron’s+1

While an early “IPO pop” often grabs attention, it’s only the first test. The tougher questions typically show up in the weeks and quarters after listing: customer acquisition costs, durability of margins, and whether growth can continue when macro conditions change.

Why this Wealthfront IPO matters for fintech and wealth management

A rare public-market test for the “robo-advisor” model

Wealthfront’s debut stands out because many automated investing tools are embedded inside much larger financial institutions. Barron’s described Wealthfront as the first publicly traded robo-advisor, turning its economics into a public, quarter-by-quarter scoreboard. Barron’s

That makes WLTH a proxy for a wider question: Can automated, low-fee wealth products become consistently profitable at scale—without relying too heavily on one macro tailwind?

Investor appetite is improving—but still selective

Today’s IPO arrives in a fintech market where investor enthusiasm has been uneven. Reuters has noted that other fintech listings in 2025 attracted strong demand at debut, and Axios underscored that some recent consumer fintech offerings have struggled to hold early gains. Reuters+1

For Wealthfront, the market’s verdict is likely to be shaped less by branding and more by its revenue composition—especially cash-management sensitivity to interest rates.

What Wealthfront does: cash management, investing, borrowing, planning

Wealthfront describes itself as a “tech-driven financial platform” offering products across cash management, investing, borrowing, and financial planning. GlobeNewswire

The company is also large by consumer fintech standards. In its IPO reporting, Wealthfront disclosed:

This mix is central to how investors will model the business. A robo-advisor with modest AUM fees looks different from a platform earning meaningfully from cash accounts.

How Wealthfront makes money: cash is the engine—and a risk

A key point highlighted in today’s coverage: cash management is not just a feature—it’s a major revenue driver. Barron’s reported that Wealthfront’s cash management service accounted for 76% of its revenue in the six months ending July 2025, and that the firm managed roughly $90 billion in assets (with over half in cash accounts). Barron’s

Wealthfront has also shown profitability in recent disclosures. Barron’s cited $339 million in revenue and $123 million in net income over the past year (as presented in that report), while IFR reported trailing-12-month revenue of $339 million and adjusted EBITDA of $154 million (46% margin). Barron’s+1

But the upside comes with a clear vulnerability: if interest rates fall, cash-product economics can compress. That sensitivity is one reason markets sometimes assign lower multiples to businesses with earnings tied heavily to rate environments—even if current profitability looks strong.

Tiger Global’s Wealthfront stake—and why “tripling” is the headline

One of the most discussed angles today is the windfall potential for early backers, particularly Tiger Global.

  • Bloomberg reporting, via WealthManagement.com, said Tiger Global held a 19.7% stake before the offering, making it one of the most significant shareholders. Wealth Management
  • IFR similarly described Tiger Global as the largest shareholder, with a roughly 20% stake, and said it has invested in Wealthfront since 2018. Ifre
  • The Information’s briefing framed the IPO as potentially tripling Tiger’s investment, underscoring how dramatically the stake’s value has increased from private-market entry points. The Information

It’s a timely narrative because Tiger Global—once the emblem of fast-moving, mega-check growth investing—has spent recent years under pressure to show realized wins. A high-profile IPO outcome (even on paper) helps reshape that story.

A quick timeline: from failed UBS deal to Nasdaq listing day

Wealthfront has been on a long road to public markets. The company was previously set to be acquired by UBS in a $1.4 billion deal that was later abandoned—an episode that’s now regularly referenced as a “what could have been” benchmark for today’s valuation. Ifre+1

Today’s IPO pricing—whether you focus on the ~$2.0 billion market value or the ~$2.6 billion fully diluted figure—puts Wealthfront above that 2022 deal value and resets the discussion around what the company can become as an independent, publicly traded platform. Axios+2Axios+2

What to watch next for WLTH stock and Wealthfront’s business

For readers following WLTH after the first trade, here are the issues that are likely to dominate the next phase of coverage:

  1. Post-IPO trading behavior: Does the stock hold above the $14 IPO price after the initial indicated strength? Investing.com+1
  2. Rate sensitivity: How much of profitability is durable if cash yields compress? (Today’s coverage suggests cash economics are central.) Barron’s+1
  3. Growth in funded clients and platform assets: Wealthfront’s scale—$88.2B platform assets and 1.3M funded clients—sets a high bar for maintaining momentum. Renaissance Capital+1
  4. Institutional support and after-market stability: Cornerstone demand matters. BlackRock and Wellington were cited as potential buyers of up to $150 million of IPO shares, a meaningful signal for deal stability. Wealth Management+2Reuters+2
  5. The lock-up and secondary dynamics: With a sizable secondary component in the IPO, investors will watch for future selling pressure once lock-ups expire. GlobeNewswire+1

Bottom line: Wealthfront’s IPO is more than a ticker launch—it’s a high-visibility test of whether a consumer-first, automation-led wealth platform can thrive in public markets with a business model closely tied to cash management and broader rate conditions. And for major shareholder Tiger Global, it’s a rare, headline-friendly reminder of what a successful exit can look like.

Stock Market Today

  • Ultragenyx Pharmaceutical Shares Surge 8.1% Weekly Amid Valuation Debate
    April 9, 2026, 2:08 AM EDT. Ultragenyx Pharmaceutical (RARE) shares rose 8.1% last week to $23.15 amid mixed performance, down 1.9% year-to-date and 31.7% over 12 months. The biotech specializes in rare disease treatments, a sector sensitive to clinical trial and regulatory updates. Despite recent gains, the company's long-term returns remain negative. A discounted cash flow (DCF) analysis values Ultragenyx at about $257.43 per share, suggesting it is 91% undervalued based on future free cash flow projections turning positive by 2026. However, actual cash flow remains negative at $501.5 million last year. Investors must weigh DCF optimism against market risks and sector volatility. Ultragenyx scores 4 out of 6 in valuation, indicating some appeal but highlighting areas needing scrutiny.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 09.04.2026

9 April 2026
LIVEMarkets rolling coverageStarted: April 9, 2026, 12:00 AM EDTUpdated: April 9, 2026, 2:19 AM EDT Ultragenyx Pharmaceutical Shares Surge 8.1% Weekly Amid Valuation Debate April 9, 2026, 2:08 AM EDT. Ultragenyx Pharmaceutical (RARE) shares rose 8.1% last week to $23.15 amid mixed performance, down 1.9% year-to-date and 31.7% over 12 months. The biotech specializes in rare disease treatments, a sector sensitive to clinical trial and regulatory updates. Despite recent gains, the company's long-term returns remain negative. A discounted cash flow (DCF) analysis values Ultragenyx at about $257.43 per share, suggesting it is 91% undervalued based on future free cash flow
Why IREN Stock Is Back in Focus as AI Ambitions Meet Funding Fears

Why IREN Stock Is Back in Focus as AI Ambitions Meet Funding Fears

8 April 2026
IREN shares rose 1.8% to $35.74 Wednesday as investors assessed its $6 billion share program and shift from bitcoin mining to AI cloud services. The company’s revenue fell to $184.7 million last quarter, with a net loss of $155.4 million. IREN recently announced a five-year, $9.7 billion AI cloud deal with Microsoft. Options trading volume hit 103,000 contracts Tuesday, with sentiment described as mixed.
Amazon Stock Could Jump 50% as Wall Street Reconsiders Its $200 Billion AI Bet

Amazon Stock Could Jump 50% as Wall Street Reconsiders Its $200 Billion AI Bet

8 April 2026
Amazon closed at $213.77 Tuesday, with BNP Paribas maintaining a $320 price target, citing strong AI demand despite Amazon’s planned $200 billion capex for 2026. The company’s February forecast of higher spending sent shares down 11.5% after hours, even as AWS revenue rose 24% to $35.6 billion in the December quarter. Alphabet and Microsoft are also ramping up AI infrastructure spending.
Sensex Soars 2,946 Points, Nifty Near 24,000 After Iran Ceasefire and RBI Pause

Sensex Soars 2,946 Points, Nifty Near 24,000 After Iran Ceasefire and RBI Pause

8 April 2026
The Sensex surged 2,946 points to 77,562.90 on Wednesday, its best day in five years, as a U.S.-Iran ceasefire and steady RBI rates pushed Indian markets higher. Brent crude fell 14.4% to $93.49 a barrel, easing pressure on the rupee, which rose 0.5% to 92.58 per dollar. All 16 major sectors gained, led by financials and auto stocks. The RBI kept its repo rate at 5.25% and forecast slower growth ahead.
Netflix Stock Draws Fresh Institutional Buying Ahead of Earnings After Goldman Upgrade

Netflix Stock Draws Fresh Institutional Buying Ahead of Earnings After Goldman Upgrade

8 April 2026
Stock Yards Bank & Trust Co. increased its Netflix stake by 1,141.9% to 29,074 shares in Q4, while Ethos Capital Management disclosed a new 19,610-share position worth $1.84 million. The moves come ahead of Netflix’s April 16 earnings report and follow a Goldman Sachs upgrade to Buy with a $120 target. Insiders Reed Hastings and Greg Peters sold shares earlier this year under preset trading plans. Netflix last traded at $98.82.
Top Stock Gainers Today (Dec. 12, 2025, 12:30 p.m. ET): cbdMD, Canopy Growth, Tilray Lead a Cannabis-Fueled Rally
Previous Story

Top Stock Gainers Today (Dec. 12, 2025, 12:30 p.m. ET): cbdMD, Canopy Growth, Tilray Lead a Cannabis-Fueled Rally

Big Tech Stocks Today Dec. 12, 2025: Broadcom and Oracle Rekindle AI Bubble Jitters as Mega Caps Slide
Next Story

Big Tech Stocks Today Dec. 12, 2025: Broadcom and Oracle Rekindle AI Bubble Jitters as Mega Caps Slide

Go toTop